ERBB2 and triple-negative breast carcinoma: In particular, HER2-type (hormone receptor (HR)-negative/ human epidermal growth factor receptor 2 (HER2)-positive) and triple-negative breast cancer (TNBC: HR-negative/HER2-negative) subtypes are more likely to metastasize to the brain.